Is there a future for cell kinetic measurements using IdUrd or BdUrd?

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 2, 2001, Pages 505-511

  Haustermans, Karin ^a,c   Fowler, Jack F ^b  

^a UH Leuven ^*  (Belgium)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Reprint Requests To: K Haustermans   (Belgium)

Author keywords

Head and neck cancer; LI; Repopulation; Tpot

Indexed keywords

BROXURIDINE; IDOXURIDINE;

CELL KINETICS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; KINETICS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FOLLOW-UP STUDIES; FORECASTING; HEAD AND NECK NEOPLASMS; HUMANS; IDOXURIDINE; MULTICENTER STUDIES; NEOPLASM STAGING; PLOIDIES; TIME FACTORS;

EID: 0035254230     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01506-6     Document Type: Conference Paper

References (37)

1. Split course versus continuous course irraddiation in the post-operative setting of squamous cell carcinoma of the head and neck
2. The effect of treatment time on tumor control in the radical radiotherapy of laryngeal cancer
3. T2 oral tongue carcinoma treated with radiotherapy; analysis of local control and complications
4. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
5. Dose time considerations of head and neck squamous cell carcinomas treated with irradiation
6. The hazard of accelerated tumor clonogen repopulation during radiotherapy
7. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy
8. Accelerated fractionation (AF) compared to conventional fractionatop, (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers; results of the EORTC 22851 randomized trial
9. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer; a randomized multicentre trial. CHART Steering Committee
10. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors; an interim report
11. Importance of overall treatment time of radiotherapy in head and neck carcinoma. Experience from the Danish head and neck cancer study
12. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
13. Is the 7-day accelerated treatment better than conventional 5-day irradiation of head and neck cancers?
14. Potential for increasing the differential response between tumors and normal tissues; can proliferation be used?
15. The molecular basis for cell cycle delays following ionizing radiation; a review
16. Tumor cell repopulation during fractionated radiotherapy. Correlation between flow cytometric and radiobiological data in three murine tumors
17. The effect of the overall treatment time of fractionated irradiation on the tumor control probability of a human soft tissue sarcoma xenograft in nude mice
18. Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time
19. Cell kinetics and repopulation during multifraction irradiation of spheroids; implications for clinical radiotherapy
20. Monoclonal antibody to 5-bromo- and 5- iododeoxyuridine; a new reagent for detection of DNA replication
21. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine
22. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample
23. Cell cycle analysis using flow cytometry
24. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells
25. Improved method for computing potential doubling time from flow cytometric data
26. Single biopsy, tumor kinetic analyses; a comparison of methods and an extension to shorter sampling intervals
27. Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry
28. Labelling indices in human tumours; to apply corrections or not-that is the question
29. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer; a multicenter analysis
30. In vivo cell kinetic measurements in human esophageal cancer; what can be learned from multiple biopsies?
31. pot) be compared between laboratories? A quality control study
32. Reproducibility of measurements of potential doubling time of tumour cells in the multi-centre NCI protocol T92-0045
33. Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating
34. Tumour proliferation assessed by combined histological and flow cytometric analysis; implications for therapy in squamous cell carcinoma in the head and neck
35. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy
36. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
37. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma; Dependency on tumor differentiation